Scutellariae radix suppresses hepatitis B virus production in human hepatoma cells

Frontiers in Bioscience - Elite

Volumn 2 E, Issue 4, 2010, Pages 1538-1547

  Tseng, Ya Ping ^a   Wu, Yi Chieh ^a   Leu, Yann Lii ^b   Yeh, Sheau Farn ^a   Chou, Chen Kung ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Core promoter; Human hepatocellular carcinoma cells; Scutellaria radix; Suppression of hepatitis B virus; Xiao Chai Hu Tang

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; PLANT EXTRACT; PRIMER DNA;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; HEPATITIS B VIRUS; HUMAN; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION; SCUTELLARIA BAICALENSIS; TUMOR CELL LINE; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; PLANT EXTRACTS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SCUTELLARIA BAICALENSIS; VIRUS REPLICATION;

EID: 77957362149     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. JH Kao, DS Chen: Global control of hepatitis B virus infection. Lancet Infect Dis, 2(7), 395-403 (2002)
2. RP Beasley: Hepatitis B virus: The major etiology of hepatocellular carcinoma. Cancer, 61(10), 1942-56 (1988)
3. YF Liaw: Therapy of chronic hepatitis B: current challenges and opportunities. J Viral Hepat, 9(6), 393-9 (2002)
4. HO Akbar: Lamivudine in chronic hepatitis B. virus. Saudi Med J, 23(8), 929-33 (2002)
5. HL Chan, AK Chui, WY Lau, FK Chan, ML Wong, CH Tse, AR Rao, J Wong, JJ Sung: Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation. J Med Virol, 68(2), 182-7 (2002)
6. K. M. Walsh, T Woodall, P Lamy, DG Wight, S Bloor, GJ Alexander: Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus. Gut, 49(3), 436-40 (2001) (Pubitemid 32802581)
7. WB. Offensperger, S Offensperger, A Keppler-Hafkemeyer, P Hafkemeyer, HE Blum: Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo. Antivir Ther, 1(3), 141-6 (1996) (Pubitemid 126690056)
8. EV Genovesi, L Lamb, I Medina, D Taylor, M Seifer, S Innaimo, RJ Colonno, JM Clark: Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection. Antiviral Res, 48(3), 197-203 (2000) (Pubitemid 32112613)
9. J Franco, K Saeian: Role of antiviral therapy in the prevention of hepatocellular carcinoma. J Vasc Interv Radiol, 13(9 Pt 2), S191-6 (2002)
10. GL Davis: Update on the management of chronic hepatitis B. Rev Gastroenterol Disord, 2(3), 106-15 (2002) (Pubitemid 35012115)
11. H Tajiri, K Kozaiwa, Y Ozaki, K Miki, K Shimuzu, S Okada: Effect of sho-saiko-to (xiao-chai-hu-tang) on HBeAg clearance in children with chronic hepatitis B virus infection and with sustained liver disease. Am J Chin Med, 19(2), 121-9 (1991)
12. H Oka, S Yamamoto, T Kuroki, S Harihara, T Marumo, SR Kim, T Monna, K Kobayashi, T Tango: Prospective study of chemoprevention of hepatocellular carcinoma with Shosaikoto (TJ-9). Cancer, 76(5), 743-9 (1995)
13. I Shimizu, YR Ma, Y. Mizobuchi, F Liu, T Miura, Y Nakai, M Yasuda, M Shiba, T Horie, S Amagaya, N Kawada, H Hori, S. Ito: Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology, 29(1), 149-60 (1999) (Pubitemid 29023997)
14. SM Akbar, K Yamamoto, M Abe, T Ninomiya, K Tanimoto, T Masumoto, K Michitaka, N Horiike, M Onji: Potent synergistic effect of sho-saiko-to, a herbal medicine, during vaccine therapy in a murine model of hepatitis B virus carrier. Eur J Clin Invest, 29(9), 786-92 (1999) (Pubitemid 29425520)
15. JS Chang, KC Wang, HW Liu, MC Chen, LC Chiang, C Lin: Sho-saiko-to (Xiao-Chai-Hu-Tang) and crude saikosaponins inhibit hepatitis B virus in a stable HBV-producing cell line. Am J Chin Med, 35(2), 341-51 (2007) (Pubitemid 46579088)
16. SF Yeh, CY Hong, YL Huang, TY Liu, KB Choo, CK Chou: Effect of an extract from Phyllanthus amarus on hepatitis B surface antigen gene expression in human hepatoma cells. Antiviral Res, 20(3), 185-92. (1993)
17. YC Chou, KS Jeng, ML Chen, HH Liu, TL Liu, YL Chen, YC Liu, CP Hu, C Chang: Evaluation of Transcriptional Efficiency of Hepatitis B Virus Covalently Closed Circular DNA by Reverse Transcription-PCR Combined with the Restriction Enzyme Digestion Method. J Virol, 79(3), 1813-23. (2005) (Pubitemid 40459126)
18. RL Huang, Q Huang, CF Chen, TT Chang, CJ Chou.: Anti-Viral Effects of Active Compounds from Antrodiacamphorata on Wild-Type and Lamivudine-Resistant Mutant HBV. The Chinese Pharmaceutical Journal, 55, 371-379 (2003) (Pubitemid 38901933)
19. RB DuBridge, P Tang, HC Hsia, PM Leong, JH Miller, MP Calos: Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol, 7(1), 379-87 (1987) (Pubitemid 17230421)
20. F Denizot, R Lang: Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods, 89(2), 271-7 (1986) (Pubitemid 16080782)
21. NJ Proudfoot, FE Baralle: Molecular cloning of human epsilon-globin gene. Proc Natl Acad Sci U S A, 76(11), 5435-9. (1979) (Pubitemid 10161638)
22. K Mullis, F Faloona, S Scharf, R Saiki, G Horn, H. Erlich: Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol, 51(Pt 1), 263-73. (1986) (Pubitemid 17076711)
23. F Galibert, E Mandart, F Fitoussi, P Tiollais, P Charnay: Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature, 281(5733), 646-50 (1979) (Pubitemid 10249039)
24. FL Graham, AJ van der Eb: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52(2), 456-67. (1973)
25. M M Bradford: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72, 248-54 (1976)
26. L Fu, X Wu, YY Kong, Y Wang: Regulation of Hepatitis B Virus Gene Expression by Its Two Enhancers. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai), 28(6), 590-599 (1996) (Pubitemid 127009055)
27. J Li, JH Ou: Differential regulation of hepatitis B virus gene expression by the Sp1 transcription factor. J Virol, 75(18), 8400-6 (2001) (Pubitemid 32768944)
28. S Gilbert, L Galarneau, A Lamontagne, S Roy, L Belanger: The hepatitis B virus core promoter is strongly activated by the liver nuclear receptor fetoprotein transcription factor or by ectopically expressed steroidogenic factor 1. J Virol, 74(11), 5032-9 (2000) (Pubitemid 30313842)
29. SJ Lin, PY Shu, C Chang, AK Ng, CP Hu: IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B. J Immunol, 171(9), 4708-16 (2003) (Pubitemid 37310588)
30. KH Schlemmer, D Haebich, H Rubsamen-Waigmann: Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science, 299(5608), 893-6 (2003) (Pubitemid 36182448)
31. TM Tan, Y Chen, KH Kong, J Bai, Y Li, SG Lim, TH Ang, Y Lam: Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl- [1, 3, 4]-oxadiazoles as potential anti-hepatitis B virus agents. Antiviral Res, 71(1), 7-14 (2006)
32. D Janmanchi, YP Tseng, KC Wang, RL Huang, CH Lin, SF Yeh: Synthesis and the biological evaluation of arylnaphthalene lignans as anti-hepatitis B virus agents. Bioorg Med Chem, 18(3), 1213-1226 (2010)
33. A Shlomai, N Paran, Y Shaul: PGC-1alpha controls hepatitis B virus through nutritional signals. Proc Natl Acad Sci U S A, 103(43), 16003-8 (2006) (Pubitemid 44657582)